Alvelestat (MPH996) for the Treatment of ALpha-1 ANTitrypsin Deficiency
Conditions: Alpha-1 Antitrypsin Deficiency (AATD); Pi*ZZ, Pi*SZ, or Pi*Null Phenotype; Emphysema or COPD Interventions: Drug: Alvelestat (MPH996); Other: Placebo Sponsors: University of Alabama at Birmingham; National Institutes of Health (NIH); Mereo BioPharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials